Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
UnitedHealth
UNH
|
+$439M |
| 3 |
Johnson & Johnson
JNJ
|
+$353M |
| 4 |
Amazon
AMZN
|
+$200M |
| 5 |
Microsoft
MSFT
|
+$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$344M |
| 2 |
JPMorgan Chase
JPM
|
+$293M |
| 3 |
Kellanova
K
|
+$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.91% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Thryv Holdings
THRY
$550M
| $9.43M | ﹤0.01% |
736,306
-258,996
| -26% | -$3.32M |
|
2277
Smith & Nephew
SNN
$16.4B
| $9.39M | ﹤0.01% |
331,740
-26,103
| -7% | -$739K |
|
2278
STRATTEC Security
STRT
$283M
| $9.36M | ﹤0.01% |
237,135
+2,875
| +1% | +$113K |
|
2279
Motorcar Parts of America
MPAA
$305M
| $9.32M | ﹤0.01% |
981,424
+20,129
| +2% | +$191K |
|
2280
International Money Express
IMXI
$430M
| $9.3M | ﹤0.01% |
736,491
-16,980
| -2% | -$214K |
|
2281
Replimune Group
REPL
$447M
| $9.27M | ﹤0.01% |
949,872
+171,709
| +22% | +$1.67M |
|
|
LIF
2282
Life360
LIF
$7.77B
| $9.23M | ﹤0.01% |
+240,417
| New | +$9.23M |
|
2283
Anika Therapeutics
ANIK
$125M
| $9.23M | ﹤0.01% |
613,972
-43,383
| -7% | -$652K |
|
|
WSR
2284
Whitestone REIT
WSR
$664M
| $9.22M | ﹤0.01% |
632,710
-21,993
| -3% | -$320K |
|
2285
Rocky Brands
RCKY
$215M
| $9.22M | ﹤0.01% |
530,621
-18,550
| -3% | -$322K |
|
|
ORLA
2286
Orla Mining
ORLA
$3.77B
| $9.2M | ﹤0.01% |
983,600
+8,649
| +0.9% | +$80.9K |
|
2287
Luxfer Holdings
LXFR
$356M
| $9.15M | ﹤0.01% |
771,154
+100,590
| +15% | +$1.19M |
|
2288
Sanofi
SNY
$115B
| $9.14M | ﹤0.01% |
164,767
+229
| +0.1% | +$12.7K |
|
2289
ARKO Corp
ARKO
$567M
| $9.12M | ﹤0.01% |
2,309,161
+458,021
| +25% | +$1.81M |
|
2290
Recursion Pharmaceuticals
RXRX
$2.11B
| $9.09M | ﹤0.01% |
1,716,775
+8,735
| +0.5% | +$46.2K |
|
2291
Hertz
HTZ
$1.99B
| $9.08M | ﹤0.01% |
2,302,766
-580,685
| -20% | -$2.29M |
|
2292
C3.ai
AI
$2.26B
| $9.07M | ﹤0.01% |
430,843
+124,228
| +41% | +$2.62M |
|
|
ENFN
2293
DELISTED
Enfusion, Inc.
ENFN
| $9.02M | ﹤0.01% |
809,336
+10,466
| +1% | +$117K |
|
2294
Globalstar
GSAT
$3.79B
| $9.02M | ﹤0.01% |
432,415
+319,285
| +282% | +$6.66M |
|
2295
Amplify Energy
AMPY
$160M
| $9.02M | ﹤0.01% |
2,412,168
-51,020
| -2% | -$191K |
|
2296
Orion Group Holdings
ORN
$299M
| $9.02M | ﹤0.01% |
1,724,073
-48,099
| -3% | -$252K |
|
2297
Sabesp
SBS
$16B
| $9.01M | ﹤0.01% |
504,303
+215,021
| +74% | +$3.84M |
|
2298
Kura Oncology
KURA
$711M
| $8.99M | ﹤0.01% |
1,362,424
-63,536
| -4% | -$419K |
|
2299
Planet Labs
PL
$3.01B
| $8.99M | ﹤0.01% |
2,659,178
+645,333
| +32% | +$2.18M |
|
2300
Excelerate Energy
EE
$770M
| $8.97M | ﹤0.01% |
312,755
+51,645
| +20% | +$1.48M |
|